Marko Popović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marko Popović has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Vera Popović
Institute of Field and Vegetable Crops, Belgrade, Serbia
2 shared publications - Aleksandar Filipovic
Niversity of Montenegro, Faculty of Medicine, Podgorica, Montenegro
1 shared publication - Aleksandar Stevanović
Academy of Applied Studies Politehnika, Katarine Ambrozić 3, 11000 Belgrade, Serbia
1 shared publication - Jelena Bošković
Metropolitan University, Belgrade, Republic of Serbia
1 shared publication - Marina Stamenović
Academy of Applied Studies Politehnika, Katarine Ambrozić 3, 11000 Belgrade, Serbia
1 shared publication - Markola Saulić
Academy of Applied Studies Politehnika, Katarine Ambrozić 3, 11000 Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by MDPI AG in Horticulturae
- Vol. 12 (11) , 1357
Amaranth, Flax, and Buckwheat Microgreens: Nutritional Quality, Bioactive Diversity, Precision Cultivation, and Health-Functional-Food Potential
Amaranth, flax, and buckwheat were selected as complementary microgreen matrices with distinct botanical origins and research priorities: betalain-associated pigmentation in amaranth, light-responsive quality traits in flax, and rutin- and flavonoid-rich profiles in buckwheat. This narrative review critically synthesizes peer-reviewed evidence on crop-specific nutritional quality, bioactive diversity, precision cultivation, food applications, bioaccessibility, safety, and functional-food potential. Direct evidence from studies explicitly investigating microgreens is distinguished from contextual evidence derived from seeds, sprouts, mature tissues, oils, flours, and processed products; numerical values from these matrices are not transferred to microgreens. Across the three crops, genotype, developmental stage, light spectrum, supplemental UV-B exposure, substrate or hydroponic design, harvest timing, and postharvest management can modify yield and quality-related traits. Pigmented amaranth is especially relevant to betalain- and color-focused applications; flax is a comparatively under-characterized oilseed-derived microgreen with informative light-response evidence; and common and Tartary buckwheat provide strong opportunities for rutin and flavonoid profiling and genotype comparison. The available literature does not support a single numerical ranking across crops, and compositional richness or in vitro antioxidant activity should not be interpreted as evidence of clinical efficacy. Standardized reporting, targeted foodomics, sensory and processing validation, safety control, resource-use assessment, and controlled human studies are priority directions for future research.
- 30 October 2026
- Published by MDPI AG in Horticulturae
- Vol. 12 (11) , 1357
Open AccessAmaranth, Flax, and Buckwheat Microgreens: Nutritional Quality, Bioactive Diversity, Precision Cultivation, and Health-Functional-Food Potential
Amaranth, flax, and buckwheat were selected as complementary microgreen matrices with distinct botanical origins and research priorities: betalain-associated pigmentation in amaranth, light-responsive quality traits in flax, and rutin- and flavonoid-rich profiles in buckwheat. This narrative review critically synthesizes peer-reviewed evidence on crop-specific nutritional quality, bioactive diversity, precision cultivation, food applications, bioaccessibility, safety, and functional-food potential. Direct evidence from studies explicitly investigating microgreens is distinguished from contextual evidence derived from seeds, sprouts, mature tissues, oils, flours, and processed products; numerical values from these matrices are not transferred to microgreens. Across the three crops, genotype, developmental stage, light spectrum, supplemental UV-B exposure, substrate or hydroponic design, harvest timing, and postharvest management can modify yield and quality-related traits. Pigmented amaranth is especially relevant to betalain- and color-focused applications; flax is a comparatively under-characterized oilseed-derived microgreen with informative light-response evidence; and common and Tartary buckwheat provide strong opportunities for rutin and flavonoid profiling and genotype comparison. The available literature does not support a single numerical ranking across crops, and compositional richness or in vitro antioxidant activity should not be interpreted as evidence of clinical efficacy. Standardized reporting, targeted foodomics, sensory and processing validation, safety control, resource-use assessment, and controlled human studies are priority directions for future research.
- Open Access
- 10 July 2025
- Published by University of Business Academy in Novi Sad - Faculty of Contemporary Arts Belgrade in Limes-Plus
- Vol. 20 (2-3) , 44-71
APPLICATION OF ARTIFICIAL INTELLIGENCE (AI) IN BIOTECHNOLOGY AND MEDICINE
Artificial Intelligence (AI) is the creation of intelligent systems that perform tasks requiring human intelligence, such as learning, problem solving, and decision-making. Humans and AI systems work together. This study summarizes the potential of AI and its application in medicine, agriculture, and biology-based industries. AI in agriculture provides solutions for food security by adapting agricultural management in a changing climate. Extreme temperatures can reduce wheat yields by 6% per °C. Digitalization in agriculture improves the collection and recording of data on soil health. A reservoir of genetic resources for crops and soil is provided in biodiversity ecosystems, which are key for the diversity of micronutrients. Traditional medicine is widely used by 60% of the world’s population, and it originates from medicinal plants from wild populations. As the field of AI evolves with more trained algorithms, the potential for its application in epidemiology, studying host-pathogen interactions, and drug design expands. AI relies on digital technology and is applied in several areas of pharmacy, adaptive medicine, gene editing (CRISPR: a new revolution in genetic technology), radiography, image processing, and drug management.AI is used to identify patterns of new drugs, optimize existing therapies, and use an individual’s genomic data and other types of health data to develop personalized treatment plans tailored to their specific needs. It is also used for data analysis, e.g., electronic health records and wearable devices, to identify patterns and correlations that may indicate the presence of a particular disease, helping to improve diagnosis accuracy and enable earlier intervention to prevent disease progression, as well as for medical imaging to identify abnormalities and diagnose diseases.
- 10 July 2025
- Published by University of Business Academy in Novi Sad - Faculty of Contemporary Arts Belgrade in Limes-Plus
- Vol. 20 (2-3) , 44-71
Open AccessAPPLICATION OF ARTIFICIAL INTELLIGENCE (AI) IN BIOTECHNOLOGY AND MEDICINE
Artificial Intelligence (AI) is the creation of intelligent systems that perform tasks requiring human intelligence, such as learning, problem solving, and decision-making. Humans and AI systems work together. This study summarizes the potential of AI and its application in medicine, agriculture, and biology-based industries. AI in agriculture provides solutions for food security by adapting agricultural management in a changing climate. Extreme temperatures can reduce wheat yields by 6% per °C. Digitalization in agriculture improves the collection and recording of data on soil health. A reservoir of genetic resources for crops and soil is provided in biodiversity ecosystems, which are key for the diversity of micronutrients. Traditional medicine is widely used by 60% of the world’s population, and it originates from medicinal plants from wild populations. As the field of AI evolves with more trained algorithms, the potential for its application in epidemiology, studying host-pathogen interactions, and drug design expands. AI relies on digital technology and is applied in several areas of pharmacy, adaptive medicine, gene editing (CRISPR: a new revolution in genetic technology), radiography, image processing, and drug management.AI is used to identify patterns of new drugs, optimize existing therapies, and use an individual’s genomic data and other types of health data to develop personalized treatment plans tailored to their specific needs. It is also used for data analysis, e.g., electronic health records and wearable devices, to identify patterns and correlations that may indicate the presence of a particular disease, helping to improve diagnosis accuracy and enable earlier intervention to prevent disease progression, as well as for medical imaging to identify abnormalities and diagnose diseases.